Filing Analysis
Regulation FD Disclosure
Filed May 05, 2026
LOW
SelectQuote, Inc. reported its financial results for the third fiscal quarter ended March 31, 2026. The filing includes the quarterly press release and an investor presentation as supplemental exhibits.
Key Facts
- Financial results reported for the third quarter ended March 31, 2026
- Filing includes Exhibit 99.1 (Press Release) and Exhibit 99.2 (Investor Presentation)
- Information furnished under Item 2.02 (Results of Operations and Financial Condition)
- Report signed by CFO Ryan M. Clement on May 5, 2026
Delisting Notice
Filed Mar 25, 2026
HIGH
SelectQuote, Inc. received a notice from the NYSE on March 19, 2026, indicating non-compliance with the minimum $1.00 average closing price requirement over a 30-day period. The company has a six-month cure period to regain compliance and is considering alternatives to address the deficiency.
Red Flags
- Stock price deficiency (trading below $1.00) indicates significant loss of market value.
- Potential for a reverse stock split if organic price recovery does not occur within the six-month window.
- Risk of delisting if compliance is not achieved by September 2026.
Key Facts
- Notice received from NYSE on March 19, 2026, regarding Section 802.01C of the NYSE Listed Company Manual.
- Average closing price of common stock was less than $1.00 per share over a consecutive 30 trading-day period.
- The company has a six-month cure period from the date of the notice to regain compliance.
- Compliance can be regained if the stock hits $1.00 on the last day of any month and averages $1.00 over the preceding 30 days.
- The company's common stock (SLQT) remains listed on the NYSE during the cure period.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.